VERIFIEDET Finance·20 May 2026neutral

Dr Reddy’s launches oral semaglutide in India

AI Summary

·Dr Reddy’s Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India, named Obeda.
·Obeda is available in three tablet strengths for daily use.
·Dr Reddy's is the second Indian company to introduce oral semaglutide domestically.